The bankruptcy underscores the great risks of investing in many of the companies that have gone public via mergers with special-purpose acquisition corporations.

23andMe bankruptcy underscores the risk of investing in most SPACs. - MarketWatch photo illustration/iStockphoto 23andMe is going bankrupt — underscoring the great ...

Just before the 23andMe SPAC deal closed ... giving investors the impression it is a risk-free investment. Some companies do not find appropriate acquisition targets and have to redeem the ...

Me on Sunday filed for bankruptcy in the U.S. after struggling with weak demand for its ancestry testing kits and a 2023 data ...

Genetic analysis company 23andMe (ME) announced this week it's declaring bankruptcy and pursuing a sale, leading many customers to pursue deleting their data from the company. 23andMe was founded ...

Stock trading platform Webull Corp saw shares fall in premarket trading today after a big spike during its first week as a ...

Elicit Brewing Co. is expected to open for business in the former Barnes & Noble space in ... also made a $300 million equity investment in 23andMe. When 23andMe went public in 2021, its ...

23andMe has partnered with GSK and created tests that can detect if consumers have an elevated risk of developing ... an investor in the longevity space, investing in the Series A round of Gameto ...